🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic presentation on radiotherapy in ALK positive #lungcancer by Gerard Walls from Queen's University Belfast 🎓 and Belfast Trust this morning at #ESTRO25 in Vienna

First up in the #ESTRO25 lung proffered papers section is Dr Abravan presents an analysis of relationship of dose distribution in emphysematous lungs. ➡️ Non-emphysematous/ whole lung dose is a stronger predictor of OS

Next up in #ESTRO25 proffered papers session re-irradiation is Dr Knap 🚨 Patients with SCLC and NSCLC selected for reRT had a long median Os after RT2, and limited toxicities, whether treated with stereotactic or long-course RT

Does #immunotherapy impact on patterns of cardiotoxicity in #lungcancer radiotherapy? ➡️ Maybe… #ESTRO25

What about #SABR / #SBRT to the primary tumour in LA-NSCLC? This study just presented at #ESTRO25 has promising survival with little toxicity rates ➡️ improvement in PFS ➡️ trend toward better OS

Great to see earlier results of Arm B of the #CONCORDE study being presented at #ESTRO25 by Gerard Walls ➡️ Arm B closed early owing to oesophageal toxicity ➡️ Recruitment to Arms A+C ongoing

#ESTRO25 📌🧠HIPPORAD HA-WBRT+SIB en 4-10 metástasis cerebrales mejora la función cognitiva y reduce tasas de depresión. #btsm #radonc ¿Y la radiocirugía? #SRS 🤔 Ofrece excelente control local y preserva cognición 🤩 pero con mayor riesgo de nuevas metástasis. Ensayos como

Gerry Hanna Makes a lot of sense to me, Gerry. In my experience of stage III, failure of primary tumour is more common than nodal failure. Hence, SBRT boost when feasible could improve outcomes

Where the stars align… at #ESTRO25 🤩 Directors and Peter Mac Radiation Oncology heros, Professors Sandro Porceddu, Gerry Hanna and Trevor Leong. Peter Mac Cancer Centre RANZCR

Huge congrats to my dear friend and colleague Corinne Faivre-Finn A highly deserved Breur Award and lecture at #ESTRO25 Corinne highlights the central importance of equality in the workplace and across #RadOnc Thank-you for all your support, mentorship, but most of all friendship

👏👏congratulations #womenwhocurie #ESTRO2025 IASLC

Huge congrats also to Liz Miles from RTTQA on her ESTRO Interdisciplinary Award and lecture. A phenomenal timeline of developing and supporting #RadOnc research in the UK and across the 🌍 #ESTRO25

Just catching up on some of the ESTRO25 sessions I couldn'get to. Very nice presentation from Dr Zeno Gouw from the NKI BD RT in LS-SCLC in patients <70 years is associated with superior outcomes

How did the Thora study acheive superior outcomes with higher dose RT in LS-SCLC with little increase in oesophageal toxicity? At #ESTRO25 this presentation suggests that keeping the overall treatment time short might be the key factor Should 60Gy BD over 4 weeks be a new SOC?

Really great to see Thoracic Sub-Study of our SARON study presented at #ESTRO25 Simultaneous delivery of CFRT to primary (+/- nodes) & SABR to thoracic mets in synchronous OM-NSCLC ➡️Acceptable acute RT-related adverse events ➡️No grade >3 adverse events observed

We had a cohort from across the MDT attend and present at ESTRO this year. A conference designed to learn and share information about all things radiotherapy. ☢️ A lot of learning to bring home and a fantastic time had at the conference.

Understand the Trinity St James’s Biobank Network (TSBN) - a crucial resource that connects leading hospitals to Trinity researchers with the primary goal of advancing medical research that directly benefits patient care tinyurl.com/mr2m7c83

We're finally here at the 2025 #CancerRetreat, online and at RCSI Eibhlin Mulroe 🌈, CEO of Cancer Trials Ireland, discusses the patient ambition in moving clinical trials forward. 🤍 #CancerRetreat #ClinicalTrials #CancerClinicalTrials

Seamus O’Reilly MD PhD opening the 5th 🇮🇪National Cancer Retreat CancerTrialsIreland 🌈👏👏 ! Key focuses today on planning for the future of Irish clinical trials for patients☘️🔬

🚀 New in Journal of Clinical Oncology - ROBOMET shorturl.at/NawNo! SABR vs standard #radiotherapy for painful bone mets. ✅ Pain relief at 1 month: 🔹 SABR (20 Gy single dose): 37% complete response 🔸 versus (8 Gy): 25% complete response ⚡ at 3-months ⬆️ withSABR: 54% vs 31%, p= .048